Contact
Please use this form to send email to PR contact of this press release:
Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
TO:
Please use this form to send email to PR contact of this press release:
Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
TO: